[Immunology of cancer].
The paper present a brief review of progress in cancer immunology in the past 50 years and its use in the immunodiagnosis, immunoprevention, and immunotherapy of cancer. Tumor markers have been a basis of the serological diagnosis of some tumors and the immunophenotyping of leukemia. Hepatitis B virus vaccination should reduce the incidence of hepatic cell carcinoma. Investigations have provided impetus to the design of molecular genetic anticancer vaccines which are being tested in the clinical setting.
Abelev
G I
GI
D000912:Antibodies, Neoplasm / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology; D014408:Biomarkers, Tumor / Q000276:immunology; D019496:Cancer Vaccines / Q000627:therapeutic use; D006801:Humans; D007159:Immunologic Tests / Q000379:methods*; D007167:Immunotherapy / Q000379:methods*; D009369:Neoplasms / Q000175:diagnosis / Q000276:immunology* / Q000517:prevention & control
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D019496:Cancer Vaccines
Immunologia raka.